Jan S Fehr (Jan Fehr)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Helicobacter Pylori Infection

Top Venues

African journal of laboratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Irene A Abela, Magdalena Schwarzmüller, Agne Ulyte, Thomas Radtke, Sarah R Haile, Priska Ammann, Alessia Raineri, Sonja Rueegg, Selina Epp, Christoph Berger, Jürg Böni, Amapola Manrique, Annette Audigé, Michael Huber, Peter W Schreiber, Thomas C Scheier, Jan S Fehr, Jacqueline Weber, Peter Rusert, Huldrych F Gunthard, Roger D Kouyos, Milo Alan Puhan, Susi Kriemler, Alexandra Trkola, Chloé Pasin
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. mBio 15 (2) (2024)
Irene A Abela, Magdalena Schwarzmüller, Agne Ulyte, Thomas Radtke, Sarah R Haile, Priska Ammann, Alessia Raineri, Sonja Rueegg, Selina Epp, Christoph Berger, Jürg Böni, Amapola Manrique, Annette Audigé, Michael Huber, Peter W Schreiber, Thomas C Scheier, Jan S Fehr, Jacqueline Weber, Peter Rusert, Huldrych F Gunthard, Roger D Kouyos, Milo Alan Puhan, Susi Kriemler, Alexandra Trkola, Chloé Pasin
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. mBio 15 (2) (2024)
Irene A Abela, Magdalena Schwarzmüller, Agne Ulyte, Thomas Radtke, Sarah R Haile, Priska Ammann, Alessia Raineri, Sonja Rueegg, Selina Epp, Christoph Berger, Jürg Böni, Amapola Manrique, Annette Audigé, Michael Huber, Peter W Schreiber, Thomas C Scheier, Jan S Fehr, Jacqueline Weber, Peter Rusert, Huldrych F Gunthard, Roger D Kouyos, Milo Alan Puhan, Susi Kriemler, Alexandra Trkola, Chloé Pasin
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. mBio (2024)
Thomas Radtke, Lisa Künzi, Julia Kopp, Manuela Rasi, Julia Braun, Kyra D Zens, Babette Winter, Alexia Anagnostopoulos, Milo Alan Puhan, Jan S Fehr
Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial. Trials 25 (1) (2024)
Thomas Radtke, Lisa Künzi, Julia Kopp, Manuela Rasi, Julia Braun, Kyra D Zens, Babette Winter, Alexia Anagnostopoulos, Milo Alan Puhan, Jan S Fehr
Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial. Trials 25 (1) (2024)
Irene A Abela, Magdalena Schwarzmüller, Agne Ulyte, Thomas Radtke, Sarah R Haile, Priska Ammann, Alessia Raineri, Sonja Rueegg, Selina Epp, Christoph Berger, Jürg Böni, Amapola Manrique, Annette Audigé, Michael Huber, Peter W Schreiber, Thomas C Scheier, Jan S Fehr, Jacqueline Weber, Peter Rusert, Huldrych F Gunthard, Roger D Kouyos, Milo Alan Puhan, Susi Kriemler, Alexandra Trkola, Chloé Pasin
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection. mBio 15 (2) (2024)
Denis Omali, Allan Buzibye, Richard Kwizera, Pauline Byakika-Kibwika, Rhoda Namakula, Joshua Matovu, Olive Mbabazi, Emmanuel Mande, Christine Wiltshire Sekaggya, Damalie Nakanjako, Ursula Gutteck, Keith P W J McAdam, Philippa Easterbrook, Andrew Kambugu, Jan S Fehr, Castelnuovo Barbara, Yukari C Manabe, Mohammed Lamorde, Daniel Mueller, Concepta Merry
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda. African journal of laboratory medicine 12 (1) (2023)
Patrizia Künzler-Heule, Axel Jeremias Schmidt, Katharina Fierz, Manuel Battegay, Sandra Engberg, Roger D Kouyos, Christiana Nöstlinger, Marcel Stoeckle, Charles Béguelin, Julie Delaloye, Patrick Schmid, Mathieu Rougemont, Dominique L Braun, Jan S Fehr, Dunja Nicca
Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS care (2023)
Patrizia Künzler-Heule, Axel Jeremias Schmidt, Katharina Fierz, Manuel Battegay, Sandra Engberg, Roger D Kouyos, Christiana Nöstlinger, Marcel Stoeckle, Charles Béguelin, Julie Delaloye, Patrick Schmid, Mathieu Rougemont, Dominique L Braun, Jan S Fehr, Dunja Nicca
Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS care (2023)
Denis Omali, Allan Buzibye, Richard Kwizera, Pauline Byakika-Kibwika, Rhoda Namakula, Joshua Matovu, Olive Mbabazi, Emmanuel Mande, Christine Wiltshire Sekaggya, Damalie Nakanjako, Ursula Gutteck, Keith P W J McAdam, Philippa Easterbrook, Andrew Kambugu, Jan S Fehr, Castelnuovo Barbara, Yukari C Manabe, Mohammed Lamorde, Daniel Mueller, Concepta Merry
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda. African journal of laboratory medicine 12 (1) (2023)
Tala Ballouz, Dominik Menges, Hélène E Aschmann, Ruedi Jung, Anja Domenghino, Jan S Fehr, Milo Alan Puhan, Viktor Von Wyl
Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study. JMIR public health and surveillance 8 (5) (2022)